Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 GBX | 0.00% | +37.14% | -64.18% |
05-10 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-64.18% | 23.92M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- STX Stock
- News Shield Therapeutics plc
- Shield Therapeutics Signs Exclusive License Deal For Accrufer In Canada